Your browser doesn't support javascript.
loading
Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression.
Luk, Ian Y; Jenkins, Laura J; Schoffer, Kael L; Ng, Irvin; Tse, Janson W T; Mouradov, Dmitri; Kaczmarczyk, Stanislaw; Nightingale, Rebecca; Burrows, Allan D; Anderson, Robin L; Arango, Diego; Dopeso, Higinio; Croft, Larry; Richardson, Mark F; Sieber, Oliver M; Liao, Yang; Mooi, Jennifer K; Vukelic, Natalia; Reehorst, Camilla M; Afshar-Sterle, Shoukat; Whitehall, Vicki L J; Fennell, Lochlan; Abud, Helen E; Tebbutt, Niall C; Phillips, Wayne A; Williams, David S; Shi, Wei; Mielke, Lisa A; Ernst, Matthias; Dhillon, Amardeep S; Clemons, Nicholas J; Mariadason, John M.
Affiliation
  • Luk IY; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
  • Jenkins LJ; La Trobe University School of Cancer Medicine, Melbourne, VIC, Australia.
  • Schoffer KL; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.
  • Ng I; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
  • Tse JWT; La Trobe University School of Cancer Medicine, Melbourne, VIC, Australia.
  • Mouradov D; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
  • Kaczmarczyk S; La Trobe University School of Cancer Medicine, Melbourne, VIC, Australia.
  • Nightingale R; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
  • Burrows AD; La Trobe University School of Cancer Medicine, Melbourne, VIC, Australia.
  • Anderson RL; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
  • Arango D; La Trobe University School of Cancer Medicine, Melbourne, VIC, Australia.
  • Dopeso H; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.
  • Croft L; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medial Research, Parkville, VIC, Australia.
  • Richardson MF; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.
  • Sieber OM; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
  • Liao Y; La Trobe University School of Cancer Medicine, Melbourne, VIC, Australia.
  • Mooi JK; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
  • Vukelic N; La Trobe University School of Cancer Medicine, Melbourne, VIC, Australia.
  • Reehorst CM; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
  • Afshar-Sterle S; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
  • Whitehall VLJ; La Trobe University School of Cancer Medicine, Melbourne, VIC, Australia.
  • Fennell L; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Abud HE; Group of Biomedical Research in Digestive Tract Tumors, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital Research Institute (VHIR), Barcelona, Spain.
  • Tebbutt NC; Group of Molecular Oncology, Biomedical Research institute of Lleida (IRBLleida), Lleida, Spain.
  • Phillips WA; Group of Biomedical Research in Digestive Tract Tumors, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital Research Institute (VHIR), Barcelona, Spain.
  • Williams DS; School of Life and Environmental Sciences, Deakin University, Geelong, VIC, Australia.
  • Shi W; School of Life and Environmental Sciences, Deakin University, Geelong, VIC, Australia.
  • Mielke LA; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medial Research, Parkville, VIC, Australia.
  • Ernst M; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.
  • Dhillon AS; Department of Surgery, The University of Melbourne, Parkville, VIC, Australia.
  • Clemons NJ; Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia.
  • Mariadason JM; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia.
Cell Death Differ ; 29(11): 2288-2302, 2022 11.
Article in En | MEDLINE | ID: mdl-35606410
ABSTRACT
Colorectal cancers (CRCs) often display histological features indicative of aberrant differentiation but the molecular underpinnings of this trait and whether it directly drives disease progression is unclear. Here, we identify co-ordinate epigenetic inactivation of two epithelial-specific transcription factors, EHF and CDX1, as a mechanism driving differentiation loss in CRCs. Re-expression of EHF and CDX1 in poorly-differentiated CRC cells induced extensive chromatin remodelling, transcriptional re-programming, and differentiation along the enterocytic lineage, leading to reduced growth and metastasis. Strikingly, EHF and CDX1 were also able to reprogramme non-colonic epithelial cells to express colonic differentiation markers. By contrast, inactivation of EHF and CDX1 in well-differentiated CRC cells triggered tumour de-differentiation. Mechanistically, we demonstrate that EHF physically interacts with CDX1 via its PNT domain, and that these transcription factors co-operatively drive transcription of the colonic differentiation marker, VIL1. Compound genetic deletion of Ehf and Cdx1 in the mouse colon disrupted normal colonic differentiation and significantly enhanced colorectal tumour progression. These findings thus reveal a novel mechanism driving epithelial de-differentiation and tumour progression in CRC.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Colorectal Neoplasms Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cell Death Differ Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Colorectal Neoplasms Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cell Death Differ Year: 2022 Document type: Article